Retinitis Pigmentosa News and Research

RSS
Retinitis pigmentosa (RP) is the name given to a group of inherited eye diseases that affect the retina (the light-sensitive part of the eye). RP causes the breakdown of photoreceptor cells (cells in the retina that detect light). Photoreceptor cells capture and process light helping us to see. As these cells breakdown and die, patients experience progressive vision loss. The most common feature of all forms of RP is a gradual breakdown of rods (retinal cells that detect dim light) and cones (retinal cells that detect light and color). Most forms of RP first cause the breakdown of rod cells. These forms of RP, sometimes called rod-cone dystrophy, usually begin with night blindness. Night blindness is somewhat like the experience normally sighted individuals encounter when entering a dark movie theatre on a bright, sunny day. However, patients with RP cannot adjust well to dark and dimly lit environments.
Case Western Reserve University receives $1.5M grant for oral drug trial to prevent blindness in RP patients

Case Western Reserve University receives $1.5M grant for oral drug trial to prevent blindness in RP patients

RPGRIP1L gene expression levels can be a potential prognostic marker for invasive breast cancer

RPGRIP1L gene expression levels can be a potential prognostic marker for invasive breast cancer

Soft ERG multi-electrode system developed for enhanced eye disease monitoring

Soft ERG multi-electrode system developed for enhanced eye disease monitoring

ZIP7: A novel target for treating degenerative diseases associated with misfolded proteins

ZIP7: A novel target for treating degenerative diseases associated with misfolded proteins

From China to Uzbekistan - United for Women’s Wellness on IWD

From China to Uzbekistan - United for Women’s Wellness on IWD

Gut bacteria may be responsible for sight loss in certain inherited eye diseases

Gut bacteria may be responsible for sight loss in certain inherited eye diseases

Study sheds light on 7-DHC's potential to induce cell death-resistant state in tumors

Study sheds light on 7-DHC's potential to induce cell death-resistant state in tumors

Engineered virus-like particles power up gene editing, correcting blindness in mice

Engineered virus-like particles power up gene editing, correcting blindness in mice

Revolutionary approach links protein analysis and single-cell study to uncover disease mechanisms

Revolutionary approach links protein analysis and single-cell study to uncover disease mechanisms

Stanford Medicine researchers find new way to measure ocular aging

Stanford Medicine researchers find new way to measure ocular aging

Researchers identify key mechanisms to address future treatments for hereditary blindness

Researchers identify key mechanisms to address future treatments for hereditary blindness

Newly discovered nanobody may lead to a treatment for Retinitis Pigmentosa

Newly discovered nanobody may lead to a treatment for Retinitis Pigmentosa

New agreement to facilitate genetic diagnosis of hereditary retinal dystrophies

New agreement to facilitate genetic diagnosis of hereditary retinal dystrophies

Alternative splicing in neurodegenerative disease and the promise of RNA-based therapeutic strategies

Alternative splicing in neurodegenerative disease and the promise of RNA-based therapeutic strategies

Study shows Alzheimer’s disease-associated retinopathy can be ameliorated by dietary lysophosphatidylcholine-EPA/DHA

Study shows Alzheimer’s disease-associated retinopathy can be ameliorated by dietary lysophosphatidylcholine-EPA/DHA

Study provides data to support gene supplementation as a treatment for autosomal dominant retinitis pigmentosa

Study provides data to support gene supplementation as a treatment for autosomal dominant retinitis pigmentosa

New small-molecule drugs show potential clinical utility in treating world’s leading causes of blindness

New small-molecule drugs show potential clinical utility in treating world’s leading causes of blindness

High-resolution atlas illustrates the development of human retina

High-resolution atlas illustrates the development of human retina

Using engineered stem cells to treat ALS and retinitis pigmentosa

Using engineered stem cells to treat ALS and retinitis pigmentosa

Research reveals molecular features of rare mtDNA mutations

Research reveals molecular features of rare mtDNA mutations

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.